Michael J. Farrell, Resmed option exercise and sale
CEO and chair, SEC Form 4, filed on September 10, 2026
$1.11 million4,991 shares, average $222.44
- Transaction date
- September 8, 2026
- Shares held after
- 466,256Direct ownership
- Change in holding
- 0.00%From the transactions in the filing
- Filing rows
- 21 is not a purchase or sale
Price context
RMD daily close, Apr 27 to October 27, 2026$253.20$146.34
Daily close
Sale
Grants, options, tax
Trade average $222.44
- Transaction price
- $222.44Weighted average
- Close on trade date
- $221.05September 8, 2026
- Latest close
- $250.72October 27, 2026
- Since the trade
- +12.71%vs the trade average
Transactions in the filing
DateTransactionSecuritySharesPriceAmountAfter
Option exercise
Common stockDirect
4,991
$146.34
$730,383
471,247
Sale
Common stockDirect
4,991
$222.44
$1.11 million
466,256
Recent filings at Resmed
Full historyPersonTransactionAmount or sharesDate